Status:
RECRUITING
A Novel Blood Test as a Biomarker in Mental Health
Lead Sponsor:
Fraser Health
Collaborating Sponsors:
Royal Columbian Hospital Foundation
Conditions:
Depression - Major Depressive Disorder
Schizophenia Disorder
Eligibility:
All Genders
19+ years
Brief Summary
This longitudinal, observational study aims to assess whether the characteristics of a novel blood peripheral biomarker can serve as indicators for depression and schizophrenia in patients at the Roya...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
March 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06856161
Start Date
March 25 2025
End Date
August 31 2027
Last Update
March 5 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Columbian Hospital
New Westminster, British Columbia, Canada, V3L 3M2